Finasteride in Houston, with the workup it actually requires.
FDA-approved finasteride as the first-line treatment for male pattern hair loss — with dutasteride as the step-up option when clinically indicated. Both with proper workup, honest discussion of trade-offs, and ongoing monitoring.
The most well-established treatment for male pattern hair loss.
Finasteride is a once-daily oral medication that blocks the enzyme responsible for converting testosterone into dihydrotestosterone (DHT) — the hormone that drives androgenetic alopecia in genetically susceptible men. By reducing scalp DHT levels by approximately 70%, finasteride halts the miniaturization of hair follicles that causes male pattern baldness, and in many men, allows partially miniaturized follicles to recover.
Finasteride 1 mg has been FDA-approved for male pattern hair loss since 1997 — nearly three decades of clinical evidence and real-world use. For most men with androgenetic alopecia, it remains the first-line oral treatment. Approximately 80–90% of men on finasteride either maintain their existing hair or experience some regrowth; the remainder are non-responders or plateau over time.
For patients who don’t respond adequately to finasteride or who have more aggressive hair loss, dutasteride is a stronger alternative that blocks both type I and type II 5-alpha reductase enzymes — reducing DHT by approximately 90% rather than 70%. Dutasteride is FDA-approved for benign prostatic hyperplasia and prescribed off-label for hair loss, with substantial clinical evidence supporting its use. We discuss both options during consultation and choose based on your specific situation.
Finasteride first, dutasteride when indicated.
For most patients, the right approach is to start with finasteride — the FDA-approved standard — and step up to dutasteride only if response is inadequate. Here’s how we think through the decision.
Finasteride 1 mg daily
The default starting point for most men with male pattern hair loss. FDA-approved, longest track record, most predictable side effect profile, and effective for the majority of patients. Most patients see stabilization within 3 months and regrowth becomes visible between 6 and 12 months. We reassess at 12 months.
Evidence: Strong · FDA-approved · 25+ years of clinical dataDutasteride 0.5 mg
Considered for patients with inadequate response to finasteride after 12 months, more aggressive pattern of loss at presentation, or strong patient preference for greater DHT suppression. Dutasteride reduces DHT by ~90% versus finasteride’s ~70% and head-to-head studies generally favor it for hair count outcomes. Off-label use, prescribed with informed consent.
Evidence: Strong for efficacy · Off-label for hair loss in the USLayered with topical minoxidil
For most patients seeking the strongest available outcome, the standard protocol combines a 5-alpha reductase inhibitor (finasteride or dutasteride) with topical or low-dose oral minoxidil. The two work through different mechanisms — DHT suppression plus follicle stimulation — and the evidence consistently supports combination therapy over monotherapy.
Evidence: Strong · Combination outperforms monotherapy in multiple studiesHair loss is multifactorial. One pill isn’t the whole answer.
Finasteride or dutasteride addresses the DHT pathway, which is the single biggest driver of male pattern hair loss. But the foundations matter for hair the same way they matter for everything else — and the patients who do best treat their hair as part of a broader picture.
The medication addresses the cause. The foundations support the outcome.
Hair growth depends on systemic health more than most patients realize. Sleep affects hair cycle. Stress raises cortisol and can trigger telogen effluvium that compounds androgenetic loss. Nutritional deficiencies — particularly iron, vitamin D, and protein — can blunt response to medication. We address the whole picture, not just the prescription.
- Iron, vitamin D, and ferritin status — checked during workup, addressed if deficient
- Topical minoxidil or oral minoxidil where appropriate — different mechanism, additive effect
- Coordination with GHK-Cu for follicle support, or PRP for hair for select patients
From consultation to first prescription, in real medicine.
Prescribing finasteride or dutasteride follows the same clinical pattern as any thoughtful prescribing decision — proper workup first, then a decision based on your specific situation.
Initial consultation
In person at our Houston clinic. We discuss your hair loss pattern and timeline, family history, what you’ve tried, current medications, and your goals. We talk through finasteride vs dutasteride honestly, including the trade-offs around FDA approval status, efficacy data, and side effect considerations.
Focused workup
Comprehensive baseline labs at LabCorp or Quest — total and free testosterone, DHT, thyroid (TSH, free T4), iron and ferritin, vitamin D, A1c, and inflammatory markers. We’re ruling out other causes of hair loss and identifying foundations to address alongside medication.
Protocol design
Your physician designs your specific protocol — typically finasteride 1 mg daily as the starting point, with consideration of adding topical or oral minoxidil. For patients with specific clinical indications (rapid progression, plateau on prior finasteride, informed preference), we may start with dutasteride 0.5 mg with full discussion of off-label status.
First prescription
FDA-approved finasteride filled at retail pharmacy (covered by most insurance). Dutasteride filled at retail pharmacy (typically affordable cash-pay even when not covered). Topical minoxidil or compounded oral minoxidil filled where indicated. Clear expectations about timeline: stabilization within 3 months, visible regrowth between 6 and 12 months.
Reassessment
Photographic comparison at 6 and 12 months alongside symptom review and tolerability check. If response is good, continue maintenance. If response is inadequate at 12 months on finasteride, we have an honest conversation about stepping up to dutasteride. If response is poor on either, we reassess for other causes and adjust the broader protocol.
Ready to start the conversation?
A 45-minute consultation with one of our physicians. We’ll review your specific hair loss pattern, walk through the medication options honestly, and decide together what fits — finasteride, dutasteride, or a broader combination protocol.
What these medications can — and can’t — do.
5-alpha reductase inhibitors are well-studied with decades of evidence. They work for most men. They also have specific limitations and considerations worth knowing before starting.
What these medications do well
- Halt progression of male pattern hair loss for most patients on therapy
- Produce visible regrowth in approximately 60–70% of patients on finasteride; somewhat higher rates on dutasteride
- Most patients tolerate them well with minimal side effects
- Predictable, well-characterized safety profile across 25+ years of finasteride data
- Insurance often covers finasteride; both are affordable cash-pay when not covered
- Combine effectively with topical or oral minoxidil for stronger outcomes
What they can’t do
- Restore hair in areas where follicles are completely lost — they preserve and partially restore existing follicles
- Be a one-time fix — effects reverse within 6–12 months if you stop taking the medication
- Be appropriate for women of reproductive age (both medications are absolutely contraindicated in pregnancy)
- Be a fit for patients with active prostate cancer or specific contraindications
- Produce results overnight — meaningful changes take 6–12 months
- Be guaranteed — a minority of patients are non-responders and we have an honest conversation if that’s you
Before you book.
Why start with finasteride instead of dutasteride?
Finasteride is FDA-approved for male pattern hair loss; dutasteride is off-label for this indication in the US. Finasteride has 25+ years of clinical data versus a smaller (though still substantial) dataset for dutasteride in hair loss specifically. For most patients, finasteride produces good results — and starting with the FDA-approved, lower-DHT-suppression option leaves room to escalate to dutasteride if needed rather than starting at the higher-suppression end of the spectrum. Patients with specific reasons to start with dutasteride (rapid progression, prior plateau on finasteride, informed preference) can do so with appropriate consent discussion.
What about the FDA boxed warning on finasteride?
In June 2022, the FDA added a boxed warning to finasteride related to potential suicidality risk based on adverse event reports. The data behind the warning is contested — a 2024 meta-analysis of over 2.2 million patients found no causal link between 5-alpha reductase inhibitors and neurological side effects, and the original signal may reflect reporting bias more than true causation. The honest version: a small minority of patients report mood effects on finasteride that resolve after discontinuation. We discuss this openly during consultation, screen for relevant history, and monitor patients throughout therapy.
What are the sexual side effects, really?
Both finasteride and dutasteride can cause sexual side effects — most commonly decreased libido, erectile dysfunction, or decreased ejaculate volume. The clinical trial rates are typically 1–4% over placebo, meaning the absolute risk is modest. Most patients tolerate the medication without these effects. For patients who do experience them, the effects are typically reversible upon discontinuation. We discuss this directly with every patient, monitor for it, and have a clear protocol if it comes up — including dose reduction, intermittent dosing, or switching approaches.
Can women take finasteride or dutasteride?
Both medications are absolutely contraindicated in pregnant women due to risk of birth defects in male fetuses. Postmenopausal women and women not at risk of pregnancy can be prescribed these medications off-label for female pattern hair loss, though the evidence base is thinner than for men and the decision is made carefully. Premenopausal women with hair loss are generally evaluated through a different framework — addressing hormonal causes, iron status, thyroid, and considering topical minoxidil as the safer first-line option. We discuss women’s hair loss during consultation and tailor the approach to the specific situation.
Do I need to take this forever?
To maintain results, yes. Both finasteride and dutasteride work as long as you take them; effects reverse within 6–12 months of stopping. This is the same maintenance question that comes up with most medications for chronic conditions. We have honest conversations about long-term planning at the outset, including the option of intermittent dosing protocols (some evidence supports thrice-weekly dutasteride as comparable to daily finasteride) and the realistic picture of what happens if you eventually discontinue.
What if I’m a non-responder?
About 10–20% of patients don’t see meaningful response to finasteride at 12 months. The honest conversation at that point includes: stepping up to dutasteride (often the next clinical move), reassessing for other contributing factors (thyroid, iron, stress, undiagnosed conditions), considering adjunctive treatments like PRP for hair, and being realistic about whether hair restoration surgery is appropriate. We don’t keep prescribing if it’s not working.
Start with a conversation, not a prescription.
A 45-minute consultation with one of our Houston physicians. We’ll review your specific situation, walk through your options honestly, and decide together what makes sense for you.